ORAGENICS

OGEN AMEX
0.4866
-0.0035
-0.71%
After Hours: 0.4895 +0.0029 +0.60% 17:02 06/18 EDT
Open
0.5048
Prev Close
0.4901
High
0.5048
Low
0.4810
Volume
414.36K
Avg Vol (3M)
1.56M
52 Week High
3.740
52 Week Low
0.3800
% Turnover
0.90%
Market Cap
22.44M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers ORAGENICS OGEN stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Oragenics, Inc. develops, markets and sells probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora. The Company is focused on offering antibiotics against infectious disease and on developing treatments for oral mucositis. It is engaged in developing its antibiotic product candidate, MU1140, as well as other homolog antibiotic product candidates; researching AG013 in connection with the treatment of Oral Mucositis; commercializing its ProBiora3 probiotic products, and has other product candidates for out licensing or partnering. MU1140 is an antibiotic that is produced by the parent of the SMaRT strain. ProBiora3 is a blend of three naturally occurring strains of beneficial bacteria, including Streptococcus oralis KJ3, Streptococcus uberis KJ2 and Streptococcus rattus JH145. LPT3-04 is a compound, which is consumed in the human diet in small amounts and results in dose-dependent weight loss in experimental animal models.
MORE >

Recently

Name
Price
%Change